Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

High Risk SCC and Mohs Micrographic Surgery

J Am Acad Dermatol; ePub 2018 Sep 19; Marrazzo, et al

Invasion beyond subcutaneous fat and poor histologic differentiation may carry a greater risk of poor outcomes than other factors in high risk cutaneous squamous cell carcinoma (hrSCC), according to a recent study. However, Mohs surgery alone provides excellent marginal control with low rates of local recurrence, nodal metastasis, and disease-specific death. Researchers conducted a retrospective chart review of all hrSCC patients treated in a clinic from October 2011 to December 2015, and found:

  • 647 hrSCC tumors that met inclusion criteria were identified.
  • During the follow-up period, there were 19 local recurrences(LR) (2.9%), 31 nodal metastases(NM) (4.8%), 7 distant metastases(DM) (1.1%), and 7 disease-specific deaths(DSD) (1.1%).
  • 2 factors—poor differentiation and invasion beyond the subcutaneous fat—were positively associated with local recurrence, nodal metastasis, and disease-specific death through multivariate analysis.
Citation:

Marrazzo G, Zitelli JA, Brodland D. Clinical outcomes in high-risk squamous cell carcinoma patients treated with Mohs micrographic surgery alone. [Published online ahead of print September 19, 2018]. J Am Acad Dermatol. doi:10.1016/j.jaad.2018.09.015.

This Week's Must Reads

Link Between AD and Autoimmune Disorders, J Am Acad Dermatol; ePub 2018 Oct 1; Narla, et al

Predictors of Mucosal Melanoma Survival, J Am Acad Dermatol; ePub 2018 Oct 5; Altieri, et al

Prevalence of Acne Vulgaris Among Patients with HS, J Am Acad Dermatol; ePub 2018 Oct 1; Wertenteil, et al

Skin Disease Epidemiology in a Diverse Population, J Drugs Dermatol; 2018 Oct; Gaulding, et al

Psoriasis Treatment Receives Tentative FDA Approval, Bausch Heath news release; 2018 Oct 8

Must Reads in Nonmelanoma Skin Cancer

High Risk SCC and Mohs Micrographic Surgery, J Am Acad Dermatol; ePub 2018 Sep 19; Marrazzo, et al

FDA Approves Libtayo for Metastatic cSCC, Sanofi news release; 2018 Sep 28

Incidence of Oral SCC Risk in Oral Lichen Planus, Int J Dermatol; ePub 2018 Sep 14; Lanoisz, et al

Nevus Development Trajectory from Age 3 to 16 Years, JAMA Dermatology; ePub 2018 Sep 12; Asdigian, et al

Evaluation of Combined Detection Method for BCC, JAMA Dermatology; ePub 2018 Aug 22; Sahu, et al